CN114478576A - Synthetic method of spiroheterocyclic compound - Google Patents
Synthetic method of spiroheterocyclic compound Download PDFInfo
- Publication number
- CN114478576A CN114478576A CN202210157582.9A CN202210157582A CN114478576A CN 114478576 A CN114478576 A CN 114478576A CN 202210157582 A CN202210157582 A CN 202210157582A CN 114478576 A CN114478576 A CN 114478576A
- Authority
- CN
- China
- Prior art keywords
- compound
- silver
- spiroheterocyclic
- synthesizing
- catalyst
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 150000001875 compounds Chemical class 0.000 title claims abstract description 54
- 238000010189 synthetic method Methods 0.000 title description 4
- 238000006243 chemical reaction Methods 0.000 claims abstract description 54
- 239000002904 solvent Substances 0.000 claims abstract description 41
- 150000008049 diazo compounds Chemical class 0.000 claims abstract description 26
- 239000003054 catalyst Substances 0.000 claims abstract description 19
- 238000000034 method Methods 0.000 claims abstract description 13
- 239000000654 additive Substances 0.000 claims abstract description 7
- 230000000996 additive effect Effects 0.000 claims abstract description 7
- 238000001308 synthesis method Methods 0.000 claims abstract description 7
- 239000012298 atmosphere Substances 0.000 claims abstract description 5
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 claims description 57
- 229910052703 rhodium Inorganic materials 0.000 claims description 10
- 239000010948 rhodium Substances 0.000 claims description 10
- 230000002194 synthesizing effect Effects 0.000 claims description 10
- MHOVAHRLVXNVSD-UHFFFAOYSA-N rhodium atom Chemical compound [Rh] MHOVAHRLVXNVSD-UHFFFAOYSA-N 0.000 claims description 9
- -1 silver hexafluoroantimonate Chemical group 0.000 claims description 8
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 claims description 6
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 claims description 6
- QVLTVILSYOWFRM-UHFFFAOYSA-L CC1=C(C)C(C)([Rh](Cl)Cl)C(C)=C1C Chemical group CC1=C(C)C(C)([Rh](Cl)Cl)C(C)=C1C QVLTVILSYOWFRM-UHFFFAOYSA-L 0.000 claims description 6
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 claims description 6
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 claims description 6
- WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid Chemical compound OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 claims description 6
- GGCZERPQGJTIQP-UHFFFAOYSA-N sodium;9,10-dioxoanthracene-2-sulfonic acid Chemical compound [Na+].C1=CC=C2C(=O)C3=CC(S(=O)(=O)O)=CC=C3C(=O)C2=C1 GGCZERPQGJTIQP-UHFFFAOYSA-N 0.000 claims description 6
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 claims description 4
- 229910052794 bromium Inorganic materials 0.000 claims description 4
- 229910052801 chlorine Inorganic materials 0.000 claims description 4
- 229910052731 fluorine Inorganic materials 0.000 claims description 4
- SCVFZCLFOSHCOH-UHFFFAOYSA-M potassium acetate Chemical compound [K+].CC([O-])=O SCVFZCLFOSHCOH-UHFFFAOYSA-M 0.000 claims description 4
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Substances [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 claims description 4
- 239000005711 Benzoic acid Substances 0.000 claims description 3
- 235000010233 benzoic acid Nutrition 0.000 claims description 3
- 239000002994 raw material Substances 0.000 claims description 3
- CQLFBEKRDQMJLZ-UHFFFAOYSA-M silver acetate Chemical compound [Ag+].CC([O-])=O CQLFBEKRDQMJLZ-UHFFFAOYSA-M 0.000 claims description 3
- SCYULBFZEHDVBN-UHFFFAOYSA-N 1,1-Dichloroethane Chemical compound CC(Cl)Cl SCYULBFZEHDVBN-UHFFFAOYSA-N 0.000 claims description 2
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 claims description 2
- GFCVQYCZHGSRMA-UHFFFAOYSA-L C(C)(=O)[O-].CC1=C(C(=C(C1([Rh+2])C)C)C)C.C(C)(=O)[O-] Chemical compound C(C)(=O)[O-].CC1=C(C(=C(C1([Rh+2])C)C)C)C.C(C)(=O)[O-] GFCVQYCZHGSRMA-UHFFFAOYSA-L 0.000 claims description 2
- SAXQOYZKDFVDTH-UHFFFAOYSA-N CC1=C(C(=C(C1(C)[Rh])C)C)C Chemical compound CC1=C(C(=C(C1(C)[Rh])C)C)C SAXQOYZKDFVDTH-UHFFFAOYSA-N 0.000 claims description 2
- ONIBWKKTOPOVIA-BYPYZUCNSA-N L-Proline Chemical compound OC(=O)[C@@H]1CCCN1 ONIBWKKTOPOVIA-BYPYZUCNSA-N 0.000 claims description 2
- ONIBWKKTOPOVIA-UHFFFAOYSA-N Proline Natural products OC(=O)C1CCCN1 ONIBWKKTOPOVIA-UHFFFAOYSA-N 0.000 claims description 2
- ZOIORXHNWRGPMV-UHFFFAOYSA-N acetic acid;zinc Chemical compound [Zn].CC(O)=O.CC(O)=O ZOIORXHNWRGPMV-UHFFFAOYSA-N 0.000 claims description 2
- 150000001555 benzenes Chemical group 0.000 claims description 2
- CZKMPDNXOGQMFW-UHFFFAOYSA-N chloro(triethyl)germane Chemical compound CC[Ge](Cl)(CC)CC CZKMPDNXOGQMFW-UHFFFAOYSA-N 0.000 claims description 2
- MBAKFIZHTUAVJN-UHFFFAOYSA-I hexafluoroantimony(1-);hydron Chemical compound F.F[Sb](F)(F)(F)F MBAKFIZHTUAVJN-UHFFFAOYSA-I 0.000 claims description 2
- 239000012299 nitrogen atmosphere Substances 0.000 claims description 2
- IUGYQRQAERSCNH-UHFFFAOYSA-N pivalic acid Chemical compound CC(C)(C)C(O)=O IUGYQRQAERSCNH-UHFFFAOYSA-N 0.000 claims description 2
- 235000011056 potassium acetate Nutrition 0.000 claims description 2
- 229910000027 potassium carbonate Inorganic materials 0.000 claims description 2
- 230000035484 reaction time Effects 0.000 claims description 2
- 229910052709 silver Inorganic materials 0.000 claims description 2
- 239000004332 silver Substances 0.000 claims description 2
- 229940071536 silver acetate Drugs 0.000 claims description 2
- YPNVIBVEFVRZPJ-UHFFFAOYSA-L silver sulfate Chemical compound [Ag+].[Ag+].[O-]S([O-])(=O)=O YPNVIBVEFVRZPJ-UHFFFAOYSA-L 0.000 claims description 2
- 229910000367 silver sulfate Inorganic materials 0.000 claims description 2
- 229910001494 silver tetrafluoroborate Inorganic materials 0.000 claims description 2
- KZJPVUDYAMEDRM-UHFFFAOYSA-M silver;2,2,2-trifluoroacetate Chemical compound [Ag+].[O-]C(=O)C(F)(F)F KZJPVUDYAMEDRM-UHFFFAOYSA-M 0.000 claims description 2
- 229910000029 sodium carbonate Inorganic materials 0.000 claims description 2
- 239000004246 zinc acetate Substances 0.000 claims description 2
- BQCADISMDOOEFD-UHFFFAOYSA-N Silver Chemical compound [Ag] BQCADISMDOOEFD-UHFFFAOYSA-N 0.000 claims 1
- 239000002253 acid Substances 0.000 claims 1
- JIMXXGFJRDUSRO-UHFFFAOYSA-N adamantane-1-carboxylic acid Chemical compound C1C(C2)CC3CC2CC1(C(=O)O)C3 JIMXXGFJRDUSRO-UHFFFAOYSA-N 0.000 claims 1
- 230000015572 biosynthetic process Effects 0.000 abstract description 12
- 238000003786 synthesis reaction Methods 0.000 abstract description 12
- 125000003003 spiro group Chemical group 0.000 abstract description 10
- 238000010276 construction Methods 0.000 abstract description 5
- 239000003814 drug Substances 0.000 abstract description 5
- 239000000758 substrate Substances 0.000 abstract description 5
- 239000000463 material Substances 0.000 abstract description 4
- 229930014626 natural product Natural products 0.000 abstract description 4
- 125000000524 functional group Chemical group 0.000 abstract description 3
- 230000007547 defect Effects 0.000 abstract 1
- HEDRZPFGACZZDS-MICDWDOJSA-N Trichloro(2H)methane Chemical compound [2H]C(Cl)(Cl)Cl HEDRZPFGACZZDS-MICDWDOJSA-N 0.000 description 68
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 42
- 239000000047 product Substances 0.000 description 35
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 34
- 230000005311 nuclear magnetism Effects 0.000 description 27
- 150000004893 oxazines Chemical class 0.000 description 18
- 238000001644 13C nuclear magnetic resonance spectroscopy Methods 0.000 description 17
- 238000005160 1H NMR spectroscopy Methods 0.000 description 17
- 238000012512 characterization method Methods 0.000 description 17
- 239000003480 eluent Substances 0.000 description 17
- 229910052757 nitrogen Inorganic materials 0.000 description 17
- 239000003208 petroleum Substances 0.000 description 17
- MEMWNTAFSYIKSU-UHFFFAOYSA-N pyran Chemical compound O1C=CC=C=C1 MEMWNTAFSYIKSU-UHFFFAOYSA-N 0.000 description 17
- 239000000741 silica gel Substances 0.000 description 17
- 229910002027 silica gel Inorganic materials 0.000 description 17
- 229910001544 silver hexafluoroantimonate(V) Inorganic materials 0.000 description 17
- 238000001228 spectrum Methods 0.000 description 17
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 16
- 239000007787 solid Substances 0.000 description 16
- 238000002844 melting Methods 0.000 description 15
- 230000008018 melting Effects 0.000 description 15
- HIXDQWDOVZUNNA-UHFFFAOYSA-N 2-(3,4-dimethoxyphenyl)-5-hydroxy-7-methoxychromen-4-one Chemical compound C=1C(OC)=CC(O)=C(C(C=2)=O)C=1OC=2C1=CC=C(OC)C(OC)=C1 HIXDQWDOVZUNNA-UHFFFAOYSA-N 0.000 description 14
- RTZKZFJDLAIYFH-UHFFFAOYSA-N ether Substances CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 14
- CMLFRMDBDNHMRA-UHFFFAOYSA-N 2h-1,2-benzoxazine Chemical compound C1=CC=C2C=CNOC2=C1 CMLFRMDBDNHMRA-UHFFFAOYSA-N 0.000 description 12
- 238000005481 NMR spectroscopy Methods 0.000 description 5
- WLWNRAWQDZRXMB-YLFCFFPRSA-N (2r,3r,4r,5s)-n,3,4,5-tetrahydroxy-1-(4-phenoxyphenyl)sulfonylpiperidine-2-carboxamide Chemical compound ONC(=O)[C@H]1[C@@H](O)[C@H](O)[C@@H](O)CN1S(=O)(=O)C(C=C1)=CC=C1OC1=CC=CC=C1 WLWNRAWQDZRXMB-YLFCFFPRSA-N 0.000 description 4
- 239000000126 substance Substances 0.000 description 4
- 229910052799 carbon Inorganic materials 0.000 description 3
- 238000006555 catalytic reaction Methods 0.000 description 3
- SRCZQMGIVIYBBJ-UHFFFAOYSA-N ethoxyethane;ethyl acetate Chemical compound CCOCC.CCOC(C)=O SRCZQMGIVIYBBJ-UHFFFAOYSA-N 0.000 description 3
- 238000007306 functionalization reaction Methods 0.000 description 3
- 238000011160 research Methods 0.000 description 3
- BNNFTTSQQXHNPA-UHFFFAOYSA-N [Rh]C1C=CC=C1 Chemical compound [Rh]C1C=CC=C1 BNNFTTSQQXHNPA-UHFFFAOYSA-N 0.000 description 2
- 125000004429 atom Chemical group 0.000 description 2
- 230000003197 catalytic effect Effects 0.000 description 2
- 125000004122 cyclic group Chemical group 0.000 description 2
- 238000011161 development Methods 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 238000003379 elimination reaction Methods 0.000 description 2
- 150000002085 enols Chemical class 0.000 description 2
- 125000000623 heterocyclic group Chemical group 0.000 description 2
- 229910052751 metal Inorganic materials 0.000 description 2
- 239000002184 metal Substances 0.000 description 2
- HZVOZRGWRWCICA-UHFFFAOYSA-N methanediyl Chemical compound [CH2] HZVOZRGWRWCICA-UHFFFAOYSA-N 0.000 description 2
- 239000000376 reactant Substances 0.000 description 2
- 238000000926 separation method Methods 0.000 description 2
- HBENZIXOGRCSQN-VQWWACLZSA-N (1S,2S,6R,14R,15R,16R)-5-(cyclopropylmethyl)-16-[(2S)-2-hydroxy-3,3-dimethylpentan-2-yl]-15-methoxy-13-oxa-5-azahexacyclo[13.2.2.12,8.01,6.02,14.012,20]icosa-8(20),9,11-trien-11-ol Chemical compound N1([C@@H]2CC=3C4=C(C(=CC=3)O)O[C@H]3[C@@]5(OC)CC[C@@]2([C@@]43CC1)C[C@@H]5[C@](C)(O)C(C)(C)CC)CC1CC1 HBENZIXOGRCSQN-VQWWACLZSA-N 0.000 description 1
- PHDIJLFSKNMCMI-ITGJKDDRSA-N (3R,4S,5R,6R)-6-(hydroxymethyl)-4-(8-quinolin-6-yloxyoctoxy)oxane-2,3,5-triol Chemical compound OC[C@@H]1[C@H]([C@@H]([C@H](C(O1)O)O)OCCCCCCCCOC=1C=C2C=CC=NC2=CC=1)O PHDIJLFSKNMCMI-ITGJKDDRSA-N 0.000 description 1
- JNPGUXGVLNJQSQ-BGGMYYEUSA-M (e,3r,5s)-7-[4-(4-fluorophenyl)-1,2-di(propan-2-yl)pyrrol-3-yl]-3,5-dihydroxyhept-6-enoate Chemical compound CC(C)N1C(C(C)C)=C(\C=C\[C@@H](O)C[C@@H](O)CC([O-])=O)C(C=2C=CC(F)=CC=2)=C1 JNPGUXGVLNJQSQ-BGGMYYEUSA-M 0.000 description 1
- VAVHMEQFYYBAPR-ITWZMISCSA-N (e,3r,5s)-7-[4-(4-fluorophenyl)-1-phenyl-2-propan-2-ylpyrrol-3-yl]-3,5-dihydroxyhept-6-enoic acid Chemical compound CC(C)C1=C(\C=C\[C@@H](O)C[C@@H](O)CC(O)=O)C(C=2C=CC(F)=CC=2)=CN1C1=CC=CC=C1 VAVHMEQFYYBAPR-ITWZMISCSA-N 0.000 description 1
- HIHOEGPXVVKJPP-JTQLQIEISA-N 5-fluoro-2-[[(1s)-1-(5-fluoropyridin-2-yl)ethyl]amino]-6-[(5-methyl-1h-pyrazol-3-yl)amino]pyridine-3-carbonitrile Chemical compound N([C@@H](C)C=1N=CC(F)=CC=1)C(C(=CC=1F)C#N)=NC=1NC=1C=C(C)NN=1 HIHOEGPXVVKJPP-JTQLQIEISA-N 0.000 description 1
- VCUKKMIXURRDKL-UHFFFAOYSA-N 9-(dimethylamino)-3-(4-ethylphenyl)pyrido[1,2]thieno[3,4-d]pyrimidin-4-one Chemical compound C1=CC(CC)=CC=C1N1C(=O)C(SC=2C3=C(N(C)C)C=CN=2)=C3N=C1 VCUKKMIXURRDKL-UHFFFAOYSA-N 0.000 description 1
- 239000002028 Biomass Substances 0.000 description 1
- JBEPFZCYCKRHTN-UHFFFAOYSA-N C(=O)O.C12CC3CC(CC(C1)C3)C2 Chemical compound C(=O)O.C12CC3CC(CC(C1)C3)C2 JBEPFZCYCKRHTN-UHFFFAOYSA-N 0.000 description 1
- DGJMHKMYSDYOFP-MRXNPFEDSA-N C=CC(N(CCC1)C[C@@H]1N1N=C(C2=CN(CC(C3=CC=CC=C3)(F)F)N=N2)C2=C(N)N=CN=C12)=O Chemical compound C=CC(N(CCC1)C[C@@H]1N1N=C(C2=CN(CC(C3=CC=CC=C3)(F)F)N=N2)C2=C(N)N=CN=C12)=O DGJMHKMYSDYOFP-MRXNPFEDSA-N 0.000 description 1
- 241000510672 Cuminum Species 0.000 description 1
- 235000007129 Cuminum cyminum Nutrition 0.000 description 1
- ZDQWESQEGGJUCH-UHFFFAOYSA-N Diisopropyl adipate Chemical compound CC(C)OC(=O)CCCCC(=O)OC(C)C ZDQWESQEGGJUCH-UHFFFAOYSA-N 0.000 description 1
- HGDWHTASNMRJMP-UHFFFAOYSA-N [1-(hydroxyamino)-1-oxo-5-(3-phenoxyphenyl)pentan-2-yl]phosphonic acid Chemical compound ONC(=O)C(P(O)(O)=O)CCCC1=CC=CC(OC=2C=CC=CC=2)=C1 HGDWHTASNMRJMP-UHFFFAOYSA-N 0.000 description 1
- 230000004913 activation Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 150000001721 carbon Chemical group 0.000 description 1
- 239000007795 chemical reaction product Substances 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 150000001923 cyclic compounds Chemical class 0.000 description 1
- 125000000664 diazo group Chemical group [N-]=[N+]=[*] 0.000 description 1
- 230000008030 elimination Effects 0.000 description 1
- 229910052736 halogen Inorganic materials 0.000 description 1
- 150000002367 halogens Chemical class 0.000 description 1
- 150000002391 heterocyclic compounds Chemical class 0.000 description 1
- 238000003780 insertion Methods 0.000 description 1
- 230000037431 insertion Effects 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- 238000006317 isomerization reaction Methods 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 230000005389 magnetism Effects 0.000 description 1
- 239000008204 material by function Substances 0.000 description 1
- OJURWUUOVGOHJZ-UHFFFAOYSA-N methyl 2-[(2-acetyloxyphenyl)methyl-[2-[(2-acetyloxyphenyl)methyl-(2-methoxy-2-oxoethyl)amino]ethyl]amino]acetate Chemical compound C=1C=CC=C(OC(C)=O)C=1CN(CC(=O)OC)CCN(CC(=O)OC)CC1=CC=CC=C1OC(C)=O OJURWUUOVGOHJZ-UHFFFAOYSA-N 0.000 description 1
- 230000005012 migration Effects 0.000 description 1
- 238000013508 migration Methods 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000007040 multi-step synthesis reaction Methods 0.000 description 1
- 238000000655 nuclear magnetic resonance spectrum Methods 0.000 description 1
- 230000000269 nucleophilic effect Effects 0.000 description 1
- 230000003287 optical effect Effects 0.000 description 1
- 150000002894 organic compounds Chemical class 0.000 description 1
- 230000037361 pathway Effects 0.000 description 1
- 235000011181 potassium carbonates Nutrition 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 238000005215 recombination Methods 0.000 description 1
- 230000006798 recombination Effects 0.000 description 1
- 238000012827 research and development Methods 0.000 description 1
- QRUBYZBWAOOHSV-UHFFFAOYSA-M silver trifluoromethanesulfonate Chemical compound [Ag+].[O-]S(=O)(=O)C(F)(F)F QRUBYZBWAOOHSV-UHFFFAOYSA-M 0.000 description 1
- HSYLTRBDKXZSGS-UHFFFAOYSA-N silver;bis(trifluoromethylsulfonyl)azanide Chemical compound [Ag+].FC(F)(F)S(=O)(=O)[N-]S(=O)(=O)C(F)(F)F HSYLTRBDKXZSGS-UHFFFAOYSA-N 0.000 description 1
- 235000017550 sodium carbonate Nutrition 0.000 description 1
- 229910052723 transition metal Inorganic materials 0.000 description 1
- 150000003624 transition metals Chemical class 0.000 description 1
- 235000013904 zinc acetate Nutrition 0.000 description 1
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D498/12—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains three hetero rings
- C07D498/20—Spiro-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Abstract
The invention provides a synthesis method of a spiro-heterocyclic compound, which is used for solving the technical problems of complex substrate synthesis, limited functional group, inadequately mild reaction conditions, difficult industrialization in the later period and other practical defects in the synthesis of the existing spiro-heterocyclic compound, and comprises the following specific steps: adding a 3-aryl benzoxazine compound, a diazo compound, a catalyst and an additive into a solvent, reacting under the protection of inert atmosphere, and purifying after the reaction is finished to obtain the spiroheterocyclic compound. The invention provides a simple and effective synthesis method for the construction of a complex spiro ring, and the method has the characteristics of mild reaction conditions, simple operation, atom economy, economic steps, strong functional group tolerance, good yield and the like; the obtained product has wide industrial application prospect, and provides a new idea and a new method for the fields of medicine, natural product synthesis, luminescent materials and the like.
Description
Technical Field
The invention belongs to the technical field of organic synthetic chemistry, and particularly relates to a synthetic method of a spiroheterocyclic compound.
Background
The C-H bond is a basic structural unit for forming an organic compound, widely exists in petrochemical industry, biomass, natural products, medicines, organic functional materials and the like, and development of simple, efficient and high-selectivity C-H bond functionalization is an important direction for researches of chemists all the time, and the fundamental reason is that: by reducing the synthesis steps of the compound, the cost is saved, the atom economy of synthesis conversion is improved, and the harm to the environment is relieved. Therefore, it is desirable to construct complex cyclic compounds using the C-H bond activation strategy. The high-efficiency functionalization of C-H bonds is an important research content of organic synthetic chemistry and one of the most challenging leading research fields, has important significance for chemical basic research and development of fields such as medicine, chemical industry, environment, energy, materials and the like, and is known as 'chemical holy cup' (Acta Chim. Sinica 2015,73,1223) by students.
Spirocycles, i.e., a special ring system in which two rings share one carbon atom, tend to have a strong rigidity and good stability in the skeleton. Also, we have readily found that the presence of a spiro backbone is often seen among biologically active natural products and biologically active molecules, and that this type of backbone is often the core backbone of many drug molecules (bioorg. Med. chem. Lett.1999,9,2921; chem. Rev.2007,107, 1011; nat. chem.2018,9, 1). In addition, the spiro skeleton also shows excellent catalytic performance and optical performance in the asymmetric catalytic field (Acc.chem.Res.2018,41,581) and the photoelectric material field (chem.Rev.,2016,116,14675; org.Electron.,2018,61, 376). In view of this, the efficient synthesis of the skeleton is always the focus of attention of synthetic chemists, and most of scientists at home and abroad realize the construction of a variety of spiro molecules by means of various synthesis methods, and especially under the promotion of a transition metal catalyst, the synthesis of the spiro skeleton takes a new step. The existing synthesis means often needs to perform pre-functionalization on a substrate (introduce halogen, a guide group and the like), so that the difficulty of the substrate in synthesis is increased, and the later removal of the guide group also limits the further development of the reaction. Meanwhile, the substrate used by the existing synthesis means generally needs multi-step synthesis, and the diversity of the obtained frameworks is limited. In addition, for complex spiro rings containing multiple ring systems, ring-by-ring construction is generally required, and the process economy is low. Therefore, the aim of synthesizing cumin by chemists is always to explore a simple and efficient synthesis means.
Disclosure of Invention
The invention provides a synthesis method of a spiro [4.5] heterocyclic compound, which adopts a simple and easily-obtained 3-arylbenzoxazine compound and a diazo compound as reactants, completes the fracture and recombination of a plurality of chemical bonds in one-step chemical transformation through a series strategy of [4+2] and [3+3] under the catalysis of cyclopentadienyl rhodium complex, prepares a spiro [5.5] heterocyclic skeleton containing a quaternary carbon center, and realizes the purposes of simple and easily-obtained reaction raw materials, mild reaction conditions and simple operation.
In order to achieve the purpose, the technical scheme of the invention is realized as follows:
a synthesis method of spiro-heterocyclic compounds takes 3-aryl benzoxazine compounds and diazo compounds as raw materials, and synthesizes novel spiro-heterocyclic compounds under the promotion of catalysts, wherein the reaction formula is as follows:
wherein R is any one of H, Me, F, Cl and Br; r1Any one of Me, Pr and Ph; r2Is Me, Et,iAny one of Pr; ar is Me, OMe, F, Cl, Br, Ph, CF3Any one of the substituted benzene rings.
The synthesis method of the spiro-heterocyclic compound comprises the following specific steps: adding a 3-aryl benzoxazine compound, a diazo compound, a catalyst and an additive into a solvent, reacting under the protection of inert atmosphere, and purifying after the reaction is finished to obtain the spiroheterocyclic compound.
The catalyst comprises a rhodium catalyst and a silver salt; the molar ratio of rhodium catalyst to silver salt is 1: (2-4); the rhodium catalyst is dichloro (pentamethylcyclopentadienyl) rhodium dimer ([ Cp & RhCl)2]2) Pentamethylcyclopentadienyl rhodium acetate (CpRh (OAc))2) Or bis (hexafluoroantimonic acid) triethylenenitrile (pentamethylcyclopentadienyl) rhodium (CpRh (CH)3CN)3(SbF6)2) Any one of the above; the silver salt is silver hexafluoroantimonate (AgSbF)6) Bis (trifluoromethanesulfonyl) imide silver (AgNTf)2) Silver tetrafluoroborate (AgBF)4) Silver trifluoromethanesulfonate (AgOTf), silver sulfate (Ag)2SO4) And silver acetate (AgOAc) and silver trifluoroacetate (AgTFA).
The catalyst consists of dichloro (pentamethylcyclopentadienyl) rhodium dimer and silver hexafluoroantimonate, and the molar ratio of the dichloro (pentamethylcyclopentadienyl) rhodium dimer to the silver hexafluoroantimonate is 1: 4.
the additive is any one of trimesoyl benzoic acid, pivalic acid, acetic acid, benzoic acid, proline, adamantane formic acid, zinc acetate, sodium carbonate, potassium acetate and potassium carbonate.
The solvent is any one of dichloroethane, dichloromethane, methanol, acetonitrile, 1, 4-dioxane and toluene.
The 3-aryl benzoxazine compound: diazo compound: catalyst: the molar ratio of the additive is 1: 2.2: 0.02-0.04: 0.08-0.16.
The concentration of the reaction system in the solvent is 0.05M-0.2M.
The inert atmosphere is a nitrogen atmosphere.
The reaction temperature is 30-90 ℃, and the reaction time is 0.5-6 h.
The reaction mode of this reaction is shown in FIG. 35. Firstly, obtaining a pentabasic rhodium hetero intermediate A under the co-catalysis of rhodium and silver by a substrate 1a, then coordinating a diazo reagent with the intermediate A to obtain a rhodium carbene intermediate B, then carrying out carbene migration and insertion to obtain an intermediate C, then carrying out metal elimination to obtain an intermediate compound D, carrying out enol isomerization on the compound D, wherein enol hydroxyl attacks an imine bond to obtain an intermediate E, carrying out the interaction between the intermediate E and a metal rhodium catalyst again to obtain an intermediate F, carrying out the same quick interconversion on the intermediate F into the enol intermediate G, carrying out further nucleophilic attack on the intermediate G to obtain an intermediate H, and finally carrying out further addition-elimination reaction on the intermediate H to obtain a final target compound 4 aa.
The invention has the beneficial effects that: the invention creatively selects simple and easily obtained oxazine compounds and diazo compounds as reactants, realizes the construction of a novel spiro [5.5] heterocyclic skeleton containing a quaternary carbon center in one step by a series strategy of [4+2] and [3+3] under the catalysis of cyclopentadienyl rhodium complexes, provides a simple and effective synthetic method for the construction of a complex spiro, and has the characteristics of mild reaction conditions, simple operation, atom economy, economic steps, strong functional group tolerance, good yield and the like. The obtained product has wide industrial application prospect, and provides a new idea and a new method for the fields of medicine, natural product synthesis, luminescent materials and the like.
Drawings
FIG. 1 is nuclear magnetism of compound 4aa1H, spectrogram; FIG. 2 Nuclear magnetism of Compound 4aa13And C, spectrum.
FIG. 3 nuclear magnetism of Compound 4ba1H, spectrogram; FIG. 4 nuclear magnetism of Compound 4ba13And C, spectrum.
FIG. 5 shows nuclear magnetism of Compound 4ca1H, spectrogram; FIG. 6 shows nuclear magnetism of Compound 4ca13And C, spectrum.
FIG. 7 shows NMR spectra for Compound 4da1H, spectrogram; FIG. 8 nuclear magnetism of Compound 4da13And C, spectrum.
FIG. 9 is nuclear magnetism of Compound 4ea1H, spectrogram; FIG. 10 is nuclear magnetism of Compound 4ea13And C, spectrum.
FIG. 11 is nuclear magnetism of compound 4fa1H, spectrogram; FIG. 12 nuclear magnetism of compound 4fa13And C, spectrum.
FIG. 13 nuclear magnetism of Compound 4ga1H, spectrogram; FIG. 14 is of Compound 4gaNuclear magnetism13And C, spectrum.
FIG. 15 is nuclear magnetism of compound 4ha1H, spectrogram; FIG. 16 is nuclear magnetism of compound 4ha13And C, spectrum.
FIG. 17 is nuclear magnetism of Compound 4ia1H, spectrogram; FIG. 18 is nuclear magnetism of Compound 4ia13And C, spectrum.
FIG. 19 NMR of Compound 4ja1H, spectrogram; FIG. 20 Nuclear magnetism of Compound 4ja13And C, spectrum.
FIG. 21 nuclear magnetism of Compound 4ka1H, spectrogram; FIG. 22 is nuclear magnetism of Compound 4ka13And C, spectrum.
FIG. 23 is nuclear magnetism of compound 4la1H, spectrogram; FIG. 24 is nuclear magnetism of compound 4la13And C, spectrum.
FIG. 25 nuclear magnetism of Compound 4ma1H, spectrogram; FIG. 26 nuclear magnetism of Compound 4ma13And C, spectrum.
FIG. 27 Nuclear magnetism of Compound 4na1H, spectrogram; FIG. 28 is nuclear magnetism of compound 4na13And C, spectrum.
FIG. 29 is nuclear magnetism of Compound 4ab1H, spectrogram; FIG. 30 NMR of Compound 4ab13And C, spectrum.
FIG. 31 nuclear magnetism of Compound 4ac1H, spectrogram; FIG. 32 NMR of Compound 4ac13And C, spectrum.
FIG. 33 NMR of Compound 4ad1H, spectrogram; FIG. 34 NMR of Compound 4ad13And C, spectrum.
FIG. 35 is a reaction scheme of the synthetic pathway.
Detailed Description
The technical solutions in the embodiments of the present invention will be clearly and completely described below with reference to the drawings in the embodiments of the present invention, and it is obvious that the described embodiments are only a part of the embodiments of the present invention, and not all of the embodiments. All other embodiments, which can be obtained by a person skilled in the art without inventive effort based on the embodiments of the present invention, are within the scope of the present invention.
Example 1
Under the condition of nitrogen, 3-aryl benzoxazine compound 1a (0.20mmol), diazo compound 2a (0.44mmol), [ Cp + RhCl2]2(4mol%),AgSbF6(16 mol%), MesCOOH (0.4mmol) and solvent DCE (2.0mL) were added into a 10mL sealed tube, reacted in a 30 ℃ reaction block for 30min, after the reaction was completed, the solvent was removed under reduced pressure, and the desired product, 8, 14-dimethyl-6H-benzo [5,6 ], was isolated by silica gel column][1,4]Oxazines [3,4-a ]]Pyran [4,3,2-ij ]]Isoquinoline-9, 13-dicarboxylic acid diethyl ester (4aa), and all eluents are petroleum ether, ethyl acetate and dichloromethane which are prepared according to the ratio of 30:1: 1.
And (3) product data characterization: brown liquid, 88% yield. As shown in figures 1 and 2 of the drawings,1H NMR(400MHz,CDCl3)δ7.47(dd,J=8.0,1.0Hz,1H),7.30(t,J=8.0Hz,1H),7.18–7.06(m,3H),6.97–6.88(m,2H),4.55(d,J=11.4Hz,1H),4.37–4.31(ddt,J=9.4,7.1,3.7Hz,4H),4.16(d,J=11.4Hz,1H),2.14(s,3H),2.09(s,3H),1.37(t,J=7.1Hz,6H).13C NMR(101MHz,CDCl3)δ168.5,166.6,160.2,149.3,143.7,130.2,128.2,128.1,126.9,125.5,121.6,121.5,119.9,116.7,115.0,109.0,105.7,86.2,64.1,60.9,60.8,19.5,19.3,14.4.HRMS[M+H]+calculated for C26H26NO6 +=448.1755,found:448.1758.
example 2
Under the condition of nitrogen, 3-aryl benzoxazine compound 1b (0.20mmol), diazo compound 2a (0.44mmol), [ Cp + RhCl2]2(2mol%),AgSbF6(8mol percent), MesCOOH (0.4mmol) and a solvent DCE (2.0mL) are added into a 10mL sealed tube and reacted for 1H in a 40-degree reaction module, the solvent is removed under reduced pressure after the reaction is finished, and the target product, 4-bromo-8, 14-dimethyl-6H-benzo [ 5], is obtained by silica gel column separation,6][1,4]Oxazines [3,4-a ]]Pyran [4,3,2-ij ]]Isoquinoline-9, 13-dicarboxylic acid diethyl ester (4ba), and all eluents are petroleum ether, ethyl acetate and dichloromethane which are prepared according to the ratio of 30:1: 1.
And (3) product data characterization: white solid, 88% yield. Melting range: 127 ℃ and 128 ℃. As shown in figures 3 and 4 of the drawings,1H NMR(400MHz,CDCl3)δ7.48(d,J=7.9Hz,1H),7.43(dd,J=8.0,1.2Hz,1H),7.32(t,J=8.0Hz,1H),7.14(d,J=7.9Hz,1H),7.06(dd,J=8.0,1.2Hz,1H),6.83(t,J=8.0Hz,1H),4.71(d,J=11.4Hz,1H),4.39–4.30(m,4H),4.24(d,J=11.4Hz,1H),2.12(s,3H),2.09(s,3H),1.38–1.35(m,6H).13C NMR(101MHz,CDCl3)δ168.2,166.4,159.7,146.1,142.9,130.4,130.3,128.1,127.9,127.3,126.7,121.8,121.6,120.4,114.9,110.3,109.2,106.4,85.8,64.9,60.9,60.8,19.3,19.2,14.4,14.4.HRMS[M+H]+calculated for C26H25BrNO6 +=526.0860,found:526.0861.
example 3
Under the condition of nitrogen, 3-aryl benzoxazine compound 1c (0.20mmol), diazo compound 2a (0.44mmol), [ Cp + RhCl2]2(3mol%),AgSbF6(12 mol%), MesCOOH (0.4mmol) and solvent DCE (2.0mL) were added into a 10mL sealed tube, reacted in a 40 ℃ reaction block for 30min, after the reaction was completed, the solvent was removed under reduced pressure, and the desired product, 3-fluoro-8, 14-dimethyl-6H-benzo [5,6 ] was isolated by silica gel column][1,4]Oxazines [3,4-a ]]Pyran [4,3,2-ij ]]Isoquinoline-9, 13-dicarboxylic acid diethyl ester (4ca), and all eluents are petroleum ether, ethyl acetate and dichloromethane which are prepared according to the ratio of 30:1: 1.
And (3) product data characterization: white solid, 73% yield. Melting range: 180 ℃ and 181 ℃. As shown in figures 5 and 6 of the drawings,1H NMR(400MHz,CDCl3)δ7.47(d,J=7.9Hz,1H),7.30(t,J=8.0Hz,1H),7.13(d,J=7.9Hz,1H),7.03(dd,J=8.5,6.1Hz,1H),6.67(dd,J=13.2,5.7Hz,2H),4.52(d,J=11.4Hz,1H),4.43–4.27(m,4H),4.15(d,J=11.5Hz,1H),2.10(s,3H),2.10(s,3H),1.38–1.35(m,6H).13C NMR(101MHz,CDCl3)δ168.3,166.5,161.1(d,J=244.8Hz),159.8,150.2,150.0,143.5,130.3,128.7(d,J=10.0Hz),128.1,121.8(d,J=3.0Hz),121.7,121.5,114.7,109.0,107.1(d,J=23.0Hz),105.9,103.9(d,J=26.0Hz),86.1,64.0,60.9,60.8,19.3,19.3,14.4,14.4.HRMS[M+H]+calculated for C26H25FNO6 +=466.1660,found:466.1661
example 4
Under the condition of nitrogen, 3-aryl benzoxazine compound 1d (0.20mmol), diazo compound 2a (0.44mmol), [ Cp + RhCl2]2(4mol%),AgSbF6(16 mol%), MesCOOH (0.4mmol) and solvent DCE (2.0mL) were added in a 10mL sealed tube, reacted for 2H in a 40 ℃ reaction block, after the reaction was completed, the solvent was removed under reduced pressure, and the desired product, 3-chloro-8, 14-dimethyl-6H-benzo [5,6 ] was isolated by silica gel column][1,4]Oxazines [3,4-a ]]Pyran [4,3,2-ij ]]Isoquinoline-9, 13-dicarboxylic acid diethyl ester (4da), and all eluents are petroleum ether, ethyl acetate and dichloromethane which are prepared according to the ratio of 30:1: 1.
And (3) product data characterization: white solid, 84% yield. Melting range: 201 ℃ and 202 ℃. As shown in figures 7 and 8 of the drawings,1H NMR(400MHz,CDCl3)δ7.48(d,J=7.8Hz,1H),7.30(t,J=8.0Hz,1H),7.12(d,J=7.5Hz,1H),7.01(d,J=8.4Hz,1H),6.95–6.91(m,2H),4.54(d,J=11.4Hz,1H),4.40–4.28(m,4H),4.14(d,J=11.4Hz,1H),2.11(s,3H),2.11(s,3H),1.39–1.35(m,6H).13C NMR(101MHz,CDCl3)δ168.3,166.5,159.9,149.8,143.0,131.9,130.3,128.7,128.2,128.0,124.3,121.8,121.6,120.2,116.9,114.7,109.1,106.2,86.0,64.1,61.0,60.9,19.3,19.3,14.4.HRMS[M+H]+calculated for C26H25ClNO6 +=482,1365,found:482.1364.
example 5
Under the condition of nitrogen, 3-aryl benzoxazine compound 1e (0.20mmol), diazo compound 2a (0.44mmol), [ Cp + RhCl2]2(2mol%),AgSbF6(8 mol%), MesCOOH (0.4mmol) and solvent DCE (2.0mL) were added to a 10mL sealed tube, reacted in a 30 ℃ reaction block for 0.5H, after the reaction was complete, the solvent was removed under reduced pressure, and the desired product, 3-bromo-8, 14-dimethyl-6H-benzo [5,6 ] -was isolated on a silica gel column][1,4]Oxazines [3,4-a ]]Pyran [4,3,2-ij ]]Isoquinoline-9, 13-dicarboxylic acid diethyl ester (4ea), and all eluents are petroleum ether, ethyl acetate and dichloromethane which are prepared according to the ratio of 30:1: 1.
And (3) product data characterization: white solid, 81% yield. Melting range: 195 ℃ and 196 ℃. As shown in figures 9 and 10 of the drawings,1H NMR(400MHz,CDCl3)δ7.47(d,J=7.4Hz,1H),7.30(t,J=8.0Hz,1H),7.16–7.03(m,3H),6.95(d,J=8.5Hz,1H),4.54(d,J=11.4Hz,1H),4.45–4.25(m,4H),4.13(d,J=11.4Hz,1H),2.11(s,3H),2.11(s,3H),1.39–1.35(m,6H).13C NMR(101MHz,CDCl3)δ168.3,166.5,159.9,149.9,142.9,130.3,129.0,128.2,128.0,124.8,123.1,121.8,121.6,119.8,119.5,114.7,109.1,106.2,86.0,64.1,61.0,60.9,19.3,19.3,14.4.HRMS[M+H]+calculated for C26H25BrNO6 +=526.0860,found:526.0858.
example 6
Under the condition of nitrogen, 3-aryl benzoxazine compound 1f (0.20mmol), diazo compound 2a (0.44mmol), [ Cp + RhCl2]2(4mol%),AgSbF6(16 mol%), MesCOOH (0.4mmol) and solvent DCE (2.0mL) were added to a 10mL sealed tube, reacted in a 30 ℃ reaction block for 0.5H, after the reaction was complete, the solvent was removed under reduced pressure, and the desired product, 3,8, 14-trimethyl-6H-benzo [5,6 ] was isolated on a silica gel column][1,4]Oxazines [3,4 ]-a]Pyran [4,3,2-ij ]]Isoquinoline-9, 13-dicarboxylic acid diethyl ester (4fa), and all eluents are petroleum ether, ethyl acetate and dichloromethane which are prepared according to the ratio of 30:1: 1.
And (3) product data characterization: white solid, 87% yield. Melting range: 178 ℃ and 182 ℃. As shown in figures 11 and 12 of the drawings,1H NMR(400MHz,CDCl3)δ7.46(d,J=7.9Hz,1H),7.29(t,J=8.0Hz,1H),7.13(d,J=7.9Hz,1H),6.96(d,J=7.9Hz,1H),6.73(d,J=7.7Hz,2H),4.52(d,J=11.4Hz,1H),4.41–4.28(m,4H),4.13(d,J=11.4Hz,1H),2.33(s,3H),2.14(s,3H),2.10(s,3H),1.38–1.35(m,6H).13C NMR(101MHz,CDCl3)δ168.5,166.6,160.2,148.8,144.0,136.9,130.1,128.3,128.2,127.6,122.9,121.5,121.4,120.8,117.0,114.9,108.9,105.3,86.3,64.0,60.8,60.7,21.2,19.4,19.3,14.4.HRMS[M+H]+calculated for C27H28NO6 +=462.1911,found:462.1913.
example 7
Under the nitrogen condition, 1g (0.20mmol) of 3-aryl benzoxazine compound, 2a (0.44mmol) of diazo compound, [ Cp + RhCl2]2(4mol%),AgSbF6(16 mol%), MesCOOH (0.4mmol) and solvent DCE (2.0mL) were added into a 10mL sealed tube, reacted in a 50 ℃ reaction block for 2H, after the reaction was completed, the solvent was removed under reduced pressure, and the desired product, 2-chloro-8, 14-dimethyl-6H-benzo [5,6 ] was isolated by silica gel column][1,4]Oxazines [3,4-a ]]Pyran [4,3,2-ij ]]Isoquinoline-9, 13-dicarboxylic acid diethyl ester (4ga), and all eluents are petroleum ether, ethyl acetate and dichloromethane which are prepared according to the ratio of 30:1: 1.
And (3) product data characterization: white solid, 80% yield. Melting range: 151 ℃ and 152 ℃. As shown in figures 13 and 14 of the drawings,1H NMR(400MHz,CDCl3)δ7.48(d,J=8.0Hz,1H),7.30(t,J=8.0Hz,1H),7.12–7.08(m,3H),6.85(d,J=8.6Hz,1H),4.53(d,J=11.4Hz,1H),4.41–4.26(m,4H),4.12(d,J=11.4Hz,1H),2.14(s,3H),2.10(s,3H),1.36(t,J=7.1Hz,6H).13C NMR(101MHz,CDCl3)δ168.2,166.5,159.9,148.0,142.6,130.3,128.1,127.9,127.6,126.8,126.3,124.5,121.8,121.6,117.6,114.7,109.0,106.3,85.9,64.0,61.0,60.8,19.4,19.2,14.4.HRMS[M+H]+calculated for C26H25ClNO6 +=482.1365,found:482.1366.
example 8
Under the nitrogen condition, the 3-aryl benzoxazine compound 1h (0.20mmol), the diazo compound 2a (0.44mmol), [ Cp + RhCl2]2(4mol%),AgSbF6(16 mol%), MesCOOH (0.4mmol) and solvent DCE (2.0mL) were added into a 10mL sealed tube, reacted in a 50 ℃ reaction block for 2H, after the reaction was completed, the solvent was removed under reduced pressure, and the desired product, 1-fluoro-8, 14-dimethyl-6H-benzo [5,6 ] was isolated by silica gel column][1,4]Oxazines [3,4-a ]]Pyran [4,3,2-ij ]]Isoquinoline-9, 13-dicarboxylic acid diethyl ester (4ha), and all eluents are petroleum ether, ethyl acetate and dichloromethane which are prepared according to the ratio of 30:1: 1.
And (3) product data characterization: white solid, 47% yield. Melting range: 142 ℃ and 143 ℃. As shown in figures 15 and 16 of the drawings,1H NMR(400MHz,CDCl3)δ7.47(d,J=7.5Hz,1H),7.31(t,J=8.0Hz,1H),7.16–7.10(m,2H),6.77–6.73(m,2H),4.54(d,J=11.5Hz,1H),4.41–4.28(m,4H),4.20(d,J=11.5Hz,1H),2.15(d,J=2.7Hz,3H),2.09(s,3H),1.37(t,J=7.1Hz,6H).13C NMR(101MHz,CDCl3)δ168.2,166.6,159.7,157.7(d,J=248.0Hz),150.9(d,J=3.6Hz),144.8,130.3,128.1(d,J=18.8Hz),126.9,126.8,121.8(d,J=7.5Hz),115.6(d,J=15.6Hz),115.1,112.2(d,J=2.9Hz),109.0,107.9,107.7,106.5,85.9,64.2,60.9,60.9,19.3,17.3,17.2,14.4.HRMS[M+H]+calculated for C26H25FNO6 +=466.1660,found:466.1664.
example 9
Under the condition of nitrogen, 3-aryl benzoxazine compound 1i (0.20mmol), diazo compound 2a (0.44mmol), [ Cp + RhCl2]2(3mol%),AgSbF6(12 mol%), MesCOOH (0.4mmol) and solvent DCE (2.0mL) were added into a 10mL sealed tube, reacted in a 30 ℃ reaction block for 1H, after the reaction was completed, the solvent was removed under reduced pressure, and the desired product, 11-fluoro-8, 14-dimethyl-6H-benzo [5,6 ] was isolated by silica gel column][1,4]Oxazines [3,4-a ]]Pyran [4,3,2-ij ] s]Isoquinoline-9, 13-dicarboxylic acid diethyl ester (4ia), and all eluents are petroleum ether, ethyl acetate and dichloromethane which are prepared according to the ratio of 30:1: 1.
And (3) product data characterization: white solid, 80% yield. Melting range: 132 ℃ and 133 ℃. As shown in figures 17 and 18 of the drawings,1H NMR(400MHz,CDCl3)δ7.30(dd,J=10.6,2.4Hz,1H),7.19–7.13(m,1H),7.09(dd,J=7.9,1.4Hz,1H),6.97–6.87(m,3H),4.51(d,J=11.5Hz,1H),4.43–4.27(m,4H),4.11(d,J=11.5Hz,1H),2.17(s,3H),2.10(s,3H),1.39–1.35(m,6H).13C NMR(101MHz,CDCl3)δ167.9,166.2,164.2(d,J=243.7Hz),161.8,149.2,145.4,130.5(d,J=2.8Hz),130.4(d,J=3.3Hz),128.0,127.1,125.1,120.0,116.7,110.3(d,J=2.1Hz),108.8(d,J=26.3Hz),108.4(d,J=23.2Hz),108.2,104.8(d,J=2.3Hz),86.2,64.2,61.0,60.9,19.6,19.6,14.4,14.4.HRMS[M+H]+calculated for C26H25FNO6 +=466.1660,found:466.1661.
example 10
Under the nitrogen condition, 3-aryl benzoxazine compound 1j (0.20mmol), diazo compound 2a (0.44mmol, [ Cp + RhCl ]2]2(2mol%),AgSbF6(8 mol%), MesCOOH (0.4mmol) and solvent DCE (2.0mL) were added to a 10mL sealed tube, reacted in a 40 ℃ reaction block for 0.5h, after the reaction was complete, the solvent was removed under reduced pressure, and the desired product, 11-chloro-silica gel column, was isolated-8, 14-dimethyl-6H-benzo [5,6 ]][1,4]Oxazines [3,4-a ]]Pyran [4,3,2-ij ]]Isoquinoline-9, 13-dicarboxylic acid diethyl ester (4ja), and all eluents are prepared from petroleum ether, ethyl acetate and dichloromethane according to the ratio of 30:1: 1.
And (3) product data characterization: white solid, 82% yield. Melting range: 155 ℃ and 156 ℃. As shown in figures 19 and 20 of the drawings,1H NMR(400MHz,CDCl3)δ7.55(d,J=1.7Hz,1H),7.20–7.14(m,2H),7.09(d,J=7.8Hz,1H),6.98–6.89(m,2H),4.51(d,J=11.5Hz,1H),4.43–4.28(m,4H),4.12(d,J=11.5Hz,1H),2.16(s,3H),2.10(s,3H),1.38(t,J=7.0Hz,6H).13C NMR(101MHz,CDCl3)δ167.9,166.1,161.6,149.1,145.3,136.6,129.9,129.8,128.0,127.1,125.1,121.5,121.3,120.0,116.8,112.8,108.1,104.6,86.1,64.1,61.1,61.0,19.7,19.6,14.4,14.4.HRMS[M+H]+calculated for C26H25ClNO6 +=482,1365,found:482.1362.
example 11
Under the nitrogen condition, 3-aryl benzoxazine compound 1k (0.20mmol), diazo compound 2a (0.44mmol), [ Cp + RhCl2]2(4mol%),AgSbF6(16 mol%), MesCOOH (0.4mmol) and solvent DCE (2.0mL) were added to a 10mL sealed tube, reacted in a 30 ℃ reaction block for 0.5H, after the reaction was complete, the solvent was removed under reduced pressure, and the desired product, 11-bromo-8, 14-dimethyl-6H-benzo [5,6 ] was isolated on a silica gel column][1,4]Oxazines [3,4-a ]]Pyran [4,3,2-ij ] s]Isoquinoline-9, 13-dicarboxylic acid diethyl ester (4ka), and all eluents are petroleum ether, ethyl acetate and dichloromethane which are prepared according to the ratio of 30:1: 1.
And (3) product data characterization: yellow solid, 85% yield. Melting range: 150 ℃ to 151 ℃. As shown in figures 21 and 22 of the drawings,1H NMR(400MHz,CDCl3)δ7.71(d,J=1.4Hz,1H),7.34(d,J=1.4Hz,1H),7.16(t,J=7.7Hz,1H),7.09(d,J=7.8Hz,1H),6.93(dd,J=12.0,8.1Hz,2H),4.51(d,J=11.5Hz,1H),4.44–4.27(m,4H),4.12(d,J=11.5Hz,1H),2.16(s,3H),2.10(s,3H),1.38(t,J=7.1Hz,6H).13C NMR(101MHz,CDCl3)δ167.8,166.0,161.6,149.1,145.3,130.0,129.9,128.0,127.1,125.1,124.9,124.3,124.2,120.0,116.7,113.2,108.0,104.4,86.1,64.0,61.0,61.0,19.6,19.5,14.4,14.4.HRMS[M+H]+calculated for C26H25BrNO6 +=526.0860,found:526.0856.
example 12
Under the nitrogen condition, 1l (0.20mmol) of 3-aryl benzoxazine compound, 2a (0.44mmol) of diazo compound and [ Cp & RhCl & lt/EN & gt2]2(4mol%),AgSbF6(16 mol%), MesCOOH (0.4mmol) and solvent DCE (2.0mL) were added to a 10mL sealed tube, reacted in a 30 ℃ reaction block for 0.5H, after the reaction was complete, the solvent was removed under reduced pressure, and the desired product, 11-phenyl-8, 14-dimethyl-6H-benzo [5,6 ] was isolated on a silica gel column][1,4]Oxazines [3,4-a ]]Pyran [4,3,2-ij ]]Isoquinoline-9, 13-dicarboxylic acid diethyl ester (4la), and all eluents are petroleum ether, ethyl acetate and dichloromethane which are prepared according to the ratio of 30:1: 1.
And (3) product data characterization: white solid, 59% yield. Melting range: 156 ℃ and 157 ℃. As shown in figures 23 and 24 of the drawings,1H NMR(400MHz,CDCl3)δ7.73(d,J=7.5Hz,1H),7.56(d,J=7.5Hz,2H),7.43(t,J=7.5Hz,2H),7.39–7.33(m,2H),7.16(t,J=7.7Hz,1H),7.11(d,J=7.8Hz,1H),6.94(t,J=7.8Hz,2H),4.59(d,J=11.4Hz,1H),4.45–4.28(m,4H),4.19(d,J=11.4Hz,1H),2.18(s,3H),2.12(s,3H),1.38(t,J=7.1Hz,6H).13C NMR(101MHz,CDCl3)δ168.4,166.6,160.6,149.3,144.2,143.3,141.4,128.9,128.6,128.1,127.7,127.4,126.9,125.4,120.7,120.5,119.9,116.7,113.9,108.9,105.6,86.3,64.2,60.9,60.8,19.6,19.4,14.5,14.5.HRMS[M+H]+calculated for C32H30NO6 +=524.2068,found:524.2066.
example 13
Under the condition of nitrogen, 1m (0.20mmol) of 3-aryl benzoxazine compound, 2a (0.44mmol) of diazo compound and [ Cp & RhCl & lt/EN & gt2]2(2mol%),AgSbF6(8 mol%), MesCOOH (0.4mmol) and solvent DCE (2.0mL) were added into a 10mL sealed tube, reacted in a 60 ℃ reaction block for 0.5H, after the reaction was completed, the solvent was removed under reduced pressure, and the desired product, 11-trifluoromethyl-8, 14-dimethyl-6H-benzo [5,6 ] -was isolated by silica gel column][1,4]Oxazines [3,4-a ]]Pyran [4,3,2-ij ]]Isoquinoline-9, 13-dicarboxylic acid diethyl ester (4ma), and all eluents are prepared from petroleum ether, ethyl acetate and dichloromethane according to the ratio of 30:1: 1.
And (3) product data characterization: white solid, 72% yield. Melting range: 79 to 80 ℃. As shown in figures 25 and 26 of the drawings,1H NMR(400MHz,CDCl3)δ7.83(s,1H),7.46(s,1H),7.18(t,J=7.7Hz,1H),7.10(d,J=7.6Hz,1H),6.95(dd,J=11.9,8.0Hz,2H),4.54(d,J=11.5Hz,1H),4.46–4.26(m,4H),4.15(d,J=11.5Hz,1H),2.20(s,3H),2.13(s,3H),1.38(t,J=7.1Hz,6H).13C NMR(101MHz,CDCl3)δ167.8,166.0,162.0,149.1,145.9,132.5(d,J=31.9Hz),129.2,129.1,128.0,127.3,125.03,124.1(q,J=266.3Hz),120.1,118.3,118.3(d,J=3.8Hz),116.8,108.3,104.6,86.1,63.9,61.1,61.1,19.6,19.5,14.3,14.3.HRMS[M+H]+calculated for C27H25F3NO6 +=516.1628,found:516.1626.
example 14
Under the condition of nitrogen, 3-aryl benzoxazine compound 1n (0.20mmol), diazo compound 2a (0.44mmol), [ Cp + RhCl2]2(4mol%),AgSbF6(16 mol%), MesCOOH (0.4mmol) and solvent DCE (2.0mL) were charged into a 10mL sealed tube, reacted in a 90 ℃ reaction block for 6 hours, after the reaction was completed, the solvent was removed under reduced pressure, and the reaction product was isolated by silica gel column chromatographyTo obtain the target product 11-methoxy-8, 14-dimethyl-6H-benzo [5,6 ]][1,4]Oxazines [3,4-a ]]Pyran [4,3,2-ij ]]Isoquinoline-9, 13-dicarboxylic acid diethyl ester (4na), and all eluents are petroleum ether ethyl acetate and dichloromethane which are prepared according to the ratio of 30:1: 1.
And (3) product data characterization: white solid, 69% yield. Melting range: 183 ℃ and 184 ℃. As shown in figures 27 and 28 of the drawings,1H NMR(400MHz,CDCl3)δ7.16–7.08(m,3H),6.94–6.90(m,2H),6.70(d,J=2.2Hz,1H),4.50(d,J=11.4Hz,1H),4.09(d,J=11.4Hz,1H),3.86(s,3H),3.85(s,3H),3.80(s,3H),2.14(s,3H),2.09(s,3H).13C NMR(101MHz,CDCl3)δ168.7,167.0,161.2,161.1,149.1,144.7,129.4,129.3,128.0,126.9,125.3,119.8,116.6,108.4,107.6,107.3,107.2,105.1,86.2,64.3,55.4,51.7,51.6,19.6,19.5.HRMS[M+H]+calculated for C25H24NO7 +=450.1547,found:450.1546.
example 15
Under the condition of nitrogen, 3-aryl benzoxazine compound 1a (0.20mmol), diazo compound 2b (0.44mmol), [ Cp + RhCl2]2(4mol%),AgSbF6(16 mol%), MesCOOH (0.4mmol) and solvent DCE (2.0mL) were added to a 10mL sealed tube, reacted in a 30 ℃ reaction block for 0.5H, after the reaction was complete, the solvent was removed under reduced pressure, and the desired product, 8, 14-dimethyl-6H-benzo [5,6 ] was isolated on a silica gel column][1,4]Oxazines [3,4-a ]]Pyran [4,3,2-ij ]]Isoquinoline-9, 13-dicarboxylic acid diisopropyl ester (4ab), and all eluents are petroleum ether ethyl acetate and dichloromethane which are prepared according to the ratio of 30:1: 1.
And (3) product data characterization: white solid, 74% yield. Melting range: 138 ℃ and 139 ℃. As shown in figures 29 and 30 of the drawings,1H NMR(400MHz,CDCl3)δ7.17–7.12(m,1H),7.11–7.08(m,2H),6.94–6.90(m,2H),6.71(d,J=2.3Hz,1H),5.28–5.20(m,2H),4.52(d,J=11.4Hz,1H),4.12(d,J=11.4Hz,1H),3.79(s,3H),2.13(s,3H),2.08(s,3H),1.41–1.31(m,12H).13C NMR(101MHz,CDCl3)δ167.9,166.2,161.1,160.4,149.3,143.7,129.6,129.5,128.1,126.8,125.5,119.8,116.6,109.0,107.7,107.1,107.1,105.9,86.2,68.5,68.4,64.4,55.4,22.2,22.2,22.1,22.0,19.5,19.4.HRMS[M+H]+calculated for C29H32NO7 +=506.2173,found:506.2173.
example 16
Under the condition of nitrogen, 3-aryl benzoxazine compound 1a (0.20mmol), diazo compound 2c (0.44mmol), [ Cp + RhCl2]2(4mol%),AgSbF6(16 mol%), MesCOOH (0.4mmol) and solvent DCE (2.0mL) were charged into a 10mL sealed tube, reacted in a 30 ℃ reaction block for 0.5H, after the reaction was completed, the solvent was removed under reduced pressure, and the desired product, 8, 14-dipropyl-6H-benzo [5,6 ], was isolated by silica gel column][1,4]Oxazines [3,4-a ]]Pyran [4,3,2-ij ]]Isoquinoline-9, 13-dicarboxylic acid dimethyl ester (4ac), and all eluents are petroleum ether ethyl acetate and dichloromethane which are prepared according to the ratio of 30:1: 1.
And (3) product data characterization: yellow solid, 50% yield. As shown in figures 31 and 32 of the drawings,1H NMR(400MHz,CDCl3)δ7.17(dd,J=12.1,4.6Hz,2H),7.04(d,J=2.3Hz,1H),6.96–6.87(m,2H),6.70(d,J=2.3Hz,1H),4.45(d,J=11.4Hz,1H),4.14(d,J=11.4Hz,1H),3.85(s,3H),3.84(s,3H),3.79(s,3H),2.71–2.47(m,4H),1.42–1.25(m,4H),0.80(t,J=7.4Hz,3H),0.73(t,J=7.3Hz,3H).13C NMR(101MHz,CDCl3)δ168.7,167.2,163.3,161.2,149.8,149.2,129.6,129.3,127.3,127.1,125.7,120.0,116.5,108.4,107.5,107.3,107.1,105.0,86.4,64.5,55.5,51.8,51.7,34.4,31.8,22.4,20.6,14.0,13.9.HRMS[M+H]+calculated for C29H32NO7 +=506.2173,found:506.2164.
example 17
Under the condition of nitrogen, 3-aryl benzoxazine compound 1a (0.20mmol), diazo compound 2d (0.44mmol), [ Cp + RhCl2]2(4mol%),AgSbF6(16mol percent), MesCOOH (0.4mmol) and a solvent DCE (2.0mL) are added into a 10mL sealed tube and reacted for 5 hours in a 30-DEG reaction module, the solvent is removed under reduced pressure after the reaction is finished, and the target product 8, 14-diphenyl-6H-benzo [5,6 ] is obtained by silica gel column separation][1,4]Oxazines [3,4-a ]]Pyran [4,3,2-ij ]]Isoquinoline-9, 13-dicarboxylic acid diethyl ester (4ad), and all eluents are petroleum ether, ethyl acetate and dichloromethane which are prepared according to the ratio of 30:1: 1.
And (3) product data characterization: white solid, 49% yield. Melting range: 186 ℃ and 187 ℃. As shown in figures 33 and 34 of the drawings,1H NMR(400MHz,CDCl3)δ7.52–7.45(m,2H),7.39–7.17(m,7H),7.12(d,J=1.7Hz,1H),7.07(t,J=7.6Hz,1H),6.98(dt,J=15.2,7.8Hz,2H),6.73(d,J=7.8Hz,1H),6.39(t,J=7.6Hz,1H),6.16(d,J=8.0Hz,1H),4.87(d,J=11.4Hz,1H),4.47(d,J=11.4Hz,1H),4.14–3.95(m,2H),3.87(s,3H),3.86–3.73(m,2H),0.92(t,J=7.1Hz,3H),0.76(t,J=7.1Hz,3H).13C NMR(101MHz,CDCl3)δ167.6,167.5,161.7,157.9,148.9,146.7,134.7,133.9,130.6,130.4,130.2,129.8,129.5,129.3,128.6,128.1,128.1,128.0,127.7,126.0,125.3,119.7,116.0,109.4,107.8,107.1,107.0,106.8,87.1,64.5,61.0,60.6,55.6,13.6,13.6.HRMS[M+H]+calculated for C37H32NO7 +=602.2173,found:602.2173.
the above description is only for the purpose of illustrating the preferred embodiments of the present invention and is not to be construed as limiting the invention, and any modifications, equivalents, improvements and the like that fall within the spirit and principle of the present invention are intended to be included therein.
Claims (10)
1. A method for synthesizing a spiroheterocyclic compound, characterized in that: a3-aryl benzoxazine compound and a diazo compound are used as raw materials, and a novel spiro-heterocyclic compound is synthesized under the promotion of a catalyst, wherein the reaction formula is as follows:wherein R is any one of H, Me, F, Cl and Br; r is1Any one of Me, Pr and Ph; r2Is Me, Et,iAny one of Pr; ar is Me, OMe, F, Cl, Br, Ph, CF3Any one of the substituted benzene rings.
2. A synthesis method of spiro-heterocyclic compounds according to claim 1, characterized by comprising the specific steps of: adding a 3-aryl benzoxazine compound, a diazo compound, a catalyst and an additive into a solvent, reacting under the protection of inert atmosphere, and purifying after the reaction is finished to obtain the spiroheterocyclic compound.
3. A method of synthesizing a spiroheterocyclic compound according to claim 2, characterized in that: the catalyst comprises a rhodium catalyst and a silver salt; the molar ratio of rhodium catalyst to silver salt is 1: (2-4); the rhodium catalyst is dichloro (pentamethylcyclopentadienyl) rhodium dimer, pentamethylcyclopentadienyl rhodium acetate or bis (hexafluoroantimonic acid) triethylenenitrile (pentamethylcyclopentadienyl) rhodium; the silver salt is silver hexafluoroantimonate, silver bistrifluoromethanesulfonylimide, silver tetrafluoroborate, silver trifluoromethanesulfonate, silver sulfate, silver acetate and silver trifluoroacetate.
4. A method of synthesizing a spiroheterocyclic compound according to claim 3, characterized in that: the catalyst consists of dichloro (pentamethyl cyclopentadienyl) rhodium dimer and silver hexafluoroantimonate; the molar ratio of dichloro (pentamethylcyclopentadienyl) rhodium dimer to silver hexafluoroantimonate was 1: 4.
5. a method of synthesizing a spiroheterocyclic compound according to claim 2, characterized in that: the additive is any one of trimesobenzoic acid (MesCOOH), pivalic acid, acetic acid, benzoic acid, proline, adamantanecarboxylic acid, zinc acetate, sodium carbonate, potassium acetate and potassium carbonate.
6. A method of synthesizing a spiroheterocyclic compound according to claim 2, characterized in that: the solvent is any one of dichloroethane, dichloromethane, methanol, acetonitrile, 1, 4-dioxane and toluene.
7. A method of synthesizing a spiroheterocyclic compound according to claim 2, characterized in that: the 3-aryl benzoxazine compound: diazo compound: catalyst: the molar ratio of the additive is 1: 2.2: 0.02-0.04: 0.08-0.16.
8. A method of synthesizing a spiroheterocyclic compound according to claim 2, characterized in that: the concentration of the reaction system in the solvent is 0.05M-0.2M.
9. A method of synthesizing a spiroheterocyclic compound according to claim 2, characterized in that: the inert atmosphere is nitrogen atmosphere.
10. A method of synthesizing a spiroheterocyclic compound according to claim 2, characterized in that: the reaction temperature is 30-90 ℃, and the reaction time is 0.5-6 h.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2022101454326 | 2022-02-17 | ||
CN202210145432 | 2022-02-17 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN114478576A true CN114478576A (en) | 2022-05-13 |
Family
ID=81482821
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202210157582.9A Pending CN114478576A (en) | 2022-02-17 | 2022-02-21 | Synthetic method of spiroheterocyclic compound |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN114478576A (en) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN114957284A (en) * | 2022-06-07 | 2022-08-30 | 中国科学院生态环境研究中心 | High-efficiency synthesis method and application of natural product Lycibararine |
CN116768916A (en) * | 2023-06-20 | 2023-09-19 | 河南农业大学 | Coumarin compound containing spiropyran structure and synthetic method and application thereof |
-
2022
- 2022-02-21 CN CN202210157582.9A patent/CN114478576A/en active Pending
Non-Patent Citations (1)
Title |
---|
JING JING ZHANG ET AL.: ""Synthesis of spiropyrans via the Rh(III)-catalyzed annulation of 3-aryl-2H-benzo[b][1,4]oxazines with diazo ketoesters"", 《CHEM. COMMUN.》 * |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN114957284A (en) * | 2022-06-07 | 2022-08-30 | 中国科学院生态环境研究中心 | High-efficiency synthesis method and application of natural product Lycibararine |
CN114957284B (en) * | 2022-06-07 | 2023-06-09 | 中国科学院生态环境研究中心 | Efficient synthesis method and application of natural product Lycibarbitine |
CN116768916A (en) * | 2023-06-20 | 2023-09-19 | 河南农业大学 | Coumarin compound containing spiropyran structure and synthetic method and application thereof |
CN116768916B (en) * | 2023-06-20 | 2024-04-26 | 河南农业大学 | Coumarin compound containing spiropyran structure and synthetic method and application thereof |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN114478576A (en) | Synthetic method of spiroheterocyclic compound | |
CN113563370B (en) | Preparation method for preparing beta-boron-based ketone with alpha-position substituent by catalysis of chitosan loaded copper material | |
CN111777637A (en) | Axial chiral oxindole-derived styrene phosphine oxide catalyst and preparation method and application thereof | |
CN112592361B (en) | Fluoroboropyrrole functionalized metal organic framework material and preparation method and application thereof | |
CN110845428A (en) | Photocatalytic preparation method of 3-acyl quinoxalinone compound | |
CN110668967A (en) | Photocatalytic preparation method of alpha-ketoamide compound | |
CN108947943B (en) | Method for direct catalysis of dimerization of 5-methylfurfuryl alcohol by solid phosphotungstic acid | |
CN102229534B (en) | Method for synthesizing alkyl carbonic ester | |
CN107915653B (en) | Method for preparing amide by catalyzing ester and amine to react | |
CN106674112A (en) | Synthetic methods of 7-azaspiro[3,5]-nonane-2-ol and hydrochloride compound thereof | |
CN115991697A (en) | Method for preparing cycloheptatriene epsilon-caprolactone compound | |
CN110317170B (en) | Green synthesis method of 3-phenanthridinyl propyl formate compound | |
CN109438402B (en) | Benzofuranone derivatives and synthesis method thereof | |
CN113004248A (en) | Method for synthesizing carbazole compound by catalyzing hydrocarbon amination reaction with cobalt | |
CN112047842A (en) | 1, 4-diene compound and preparation method and application thereof | |
CN111848628A (en) | Imidazo [1,5-a ] quinoxaline-4 (5H) -ketone compound synthesized by metal-free catalysis and preparation method thereof | |
CN110655485A (en) | Preparation method of N-substituted indolone | |
CN116199614B (en) | N-axis chiral indole-pyrrole compound and synthesis method thereof | |
CN114835738B (en) | Method for preparing allyl borate by using biomass-based catalytic material | |
CN111718245B (en) | Method for preparing deuterated chemicals through photocatalytic decarboxylation conversion | |
CN114989072B (en) | Method for asymmetric catalytic synthesis of chiral 1, 4-dihydropyridine compound and application thereof | |
CN111302880B (en) | Application of iron catalyst in reduction coupling reaction and preparation method of aromatic ring and heterocyclic derivative | |
CN114685298B (en) | Method for synthesizing baclofen based on photocatalytic migration strategy | |
CN110105317B (en) | Synthesis method of 2-amino-4H-pyran and derivatives thereof | |
CN109336899B (en) | Method for synthesizing natural product gamma-lycorane |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20220513 |